hero-2
We bring together talent and expertise from across the University of Minnesota to use stem cell biology to advance regenerative medicine therapies for devastating disorders and to provide education and training for the stem cell scientists of tomorrow.

Welcome

 

 

Our Research

Our Education Programs

The bioscience and medical industries and academic research programs need intelligent, engaged, well-trained talent to fill jobs in the rapidly expanding field of regenerative medicine. The Stem Cell Institute prepares students who are ready to meet this need and who are eager to move the next generation of research forward. Learn more about our graduate programs:

  • Mark J. Osborn, PhD

    Assistant Professor

  • John E. Wagner, MD

    Professor

  • Troy Lund, MD, PhD

    Associate Professor

  • In the News

    Daniel Harki
    February 23, 2017

    The research team of Dr. Scott Kaufmann, leader of Mayo’s Anticancer Drug Action Laboratory, and Daniel Harki, a U of M assistant professor of medicinal chemistry, Stem Cell Institute member, and director of the Harki Lab, in January saw their patent application for a method of “assessing enzyme-nucleic acid complexes” published by the U.S. Patent and Trademark Office, with Mayo and the U of M named as the assignees.

    February 23, 2017

    Dr. Mehmet Oz investigates and uncovers the dangers of unregulated stem cell clinics, citing absence of scientific support for treatment.  Dr. Oz features a series of segments on his daytime television program that expose the scams that take advantage of the most vulnerable.

    Jaime Modiano
    February 15, 2017

    Jaime Modiano, SCI and UMN College of Veterinary Medicine Faculty member and colleague, Antonella Borgatti, developed and tested a cancer drug that they believe could someday help patients live longer and with fewer side effects. After leading a study treating dogs with HSA Sarcoma, a fast-spreading incurable cancer, Dr. Modiano said "We just never expected it was going to work as well as it did." 

    James Dutton
    February 1, 2017
    SCI faculty member, James Dutton, has been working with researchers from the University of Wisconsin-Madison who developed a library of artificial t
    ranscription factors (ATF's). The library consists of many millions of combinations of small DNA binding protein sequences combined with transcription activation domains. The complexity of the library allows unbiased activation of gene expression at any locus.  Using this library to screen for key regulators of the pluripotency network, they discovered three combinations of ATF's capable of inducing pluripotency without e
    xogenous expression of Oct4Dr Dutton is now applying this technology to discover new ways to reprogram cells to produce insulin secreting cells to treat diabetes.  Read "Reprogramming cell fate with a genome-scale library of artificial transcription factors" here.
     

    Weekly Research Conference

    Meets weekly in Room 1-110
    McGuire Translational Research Facility (MTRF, next to Lion's Research Building)
    [map] [shuttle schedule]

    Wednesday, March 1, 2017 - 4:00pm

    Translational control of skeletal muscle stem cells

    Colin Crist

    Colin Crist, PhD
    Assistant Professor
    Department of Human Genetics
    McGill University
    Montreal, Quebec, Canada

    Wednesday, March 8, 2017 - 4:00pm

    Cell-based therapies for Parkinson's Disease

    Marina Emborg

    Marina Emborg, Md/PhD
    Associate Professor, Medical Physics
    Stem Cell and Regenerative Medicine
    Wisconsin Institutes for Medical Research
    Madison, WI

    Wednesday, March 15, 2017 - 4:00pm

    Spring Break - No Research Conference

    Research Conferences will resume on Wednesday, March 22, 2017